Table 1.
Summary of Sylvian fissure meningiomas up to October 31, 2019.
| References | Age/Sex | Clinical features | Imaging features | Removal | Histopathology | Follow-up |
|---|---|---|---|---|---|---|
| Cushing et al. (2) | 8/M | Epilepsy | N/A | Subtotal | Psammomatous | 5y: died |
| 48/F | Epilepsy | N/A | Subtotal | Psammomatous | 1d: died | |
| Barcia-Goyanes et al. (3) | 20/F | Epilepsy | N/A | N/A | Psammomatous | N/A |
| Mori et al. (4) | 23/M | Epilepsy | N/A | Subtotal | Transitional | N/A |
| Saito et al. (5) | 31/F | Epilepsy | Hyperdense lesion in CT | Gross total | Psammomatous | N/A |
| Tsuchida et al. (6) | 46/M | Headache | N/A | Gross total | Psammomatous | 4y: relapse-free |
| Awa et al. (7) | 16/M | Headache | N/A | Gross total | Meningothelial | 2y: relapse-free |
| Okamoto et al. (9) | 27/F | Headache | N/A | Gross total | Fibroblastic | 5y: died |
| 35/F | Headache and visual impaired | Severe edema, hyperdense, and homogeneous lesion in CT | Gross total | Fibroblastic | N/A | |
| Drake et al. (8) | 3/F | Headache | N/A | Gross total | Malignant | N/A |
| Hirao et al. (10) | 34/F | Epilepsy | Homogeneous enhancement in CT | Gross total | Fibroblastic | N/A |
| Silbergeld et al. (11) | 4/F | Epilepsy | Homogeneous enhancement in CT | Subtotal, radiation therapy | Meningothelial | N/A |
| Cho et al. (12) | 2/M | Epilepsy and hemiparesis | Severe edema, hyperdense with homogeneous lesion in CT | Gross total | Transitional | 2y: relapse-free |
| Graziani et al. (13) | 19/M | Headache and hemiparesis | Moderate edema, calcifications, Hypointense in T1 and T2 | Gross total | Psammomatous | N/A |
| Mori et al. (15) | 12/M | Headache | Slight edema, well-enhanced tumor in CT and MRI | Gross total | Transitional | 1y: relapse-free |
| Chiocca et al. (14) | 26/F | Epilepsy | Slight edema, hypointense and homogeneous in T1 and T2 | Gross total | Fibroblastic | N/A |
| Matsumoto et al. (16) | 62/F | Epilepsy | Hypointense in T1 and T2 | Gross total | Psammomatous | N/A |
| Cooper et al. (17) | 4/M | Headache | Severe edema, heterogeneous intensity in T1 and T2 | Gross total | Transitional | 1y: relapse-free |
| Mitsuyama et al. (18) | 1/M | Epilepsy | Well-enhanced tumor in CT and MRI | Gross total | Fibroblastic | N/A |
| Kaplan et al. (19) | 11/M | Epilepsy | Isointense in T1 and heterogeneous intensity in T2 | Gross total | Atypical | N/A |
| Chang et al. (20) | 35/M | Epilepsy | Severe edema, isointense, and homogeneous in T1 and T2 | Subtotal, gamma-knife | Transitional | N/A |
| Mclver et al. (21) | 23/M | Epilepsy | Heterogeneous intensity in T1 and T2 | Subtotal | Chordoid | 17m: stable residual tumor |
| Samson et al. (23) | 6/M | Epilepsy | Calcification, edema, heterogeneous enhancement, hypointense on T1 and hyperintense on T2 | Gross total | N/A | 4y: relapse-free |
| Cecchi et al. (22) | 23/M | Headache and hemiparesis | Moderate edema, heterogeneous intensity in T1 and T2 | Subtotal, radiation therapy | Atypical | 2y: stable residual tumor |
| Ma et al. (25) | 53/M | Epilepsy | Homogeneous enhancement, edema | Subtotal, gamma-knife | Atypical | 2y: stable residual tumor |
| Chae et al. (24) | 69/M | Incidental | Calcification, edema, heterogeneous intensity in T2, heterogenous enhancement | Subtotal | Psammomatous | N/A |
| Aras et al. (26) | 15/M | Epilepsy | Homogeneous enhancement, hypointense on T1 and iso-hypointense on T2, mild edema | 1st surgery: subtotal 2nd surgery: gross total | Fibroblastic | 3y: relapse-free |
| 28/M | Epilepsy and hemiparesis | Heterogenous enhancement, hypointense on T1 and heterogeneous intensity on T2, edema | 1st surgery: subtotal 2nd surgery: gross total | Meningothelial | 5y: relapse-free | |
| Kim et al. (27) | 43/M | Epilepsy | Minimal calcification, Isointense in T1 and T2, ring like enhancement, edema | Subtotal | Lymphoplasmacyte-rich | 4y: stable residual tumor |
| Fukushima et al. (28) | 10/M | Epilepsy | Heterogeneous enhancement | Subtotal | Sclerosing | 1y: stable residual tumor |
| Donovan et al. (29) | 11/M | Epilepsy | Calcification, homogenous enhancement | Gross total | Transitional | 10y: relapse-free |
| 7/M | Epilepsy and headache | Calcification, homogenous enhancement | 1st surgery: subtotal 2nd surgery: subtotal | Fibroblastic | 2y: stable residual tumor | |
| 16/F | Epilepsy | Partial calcification, minimal enhancement | Subtotal | Meningothelial | 5y: stable residual tumor | |
| Brogna et al. (30) | 32/M | Headache and dizziness | Isointense on T1 and T2, homogenous enhancement | Gross total | Atypical | 3y: relapse-free |
| Yamagishi et al. (32) | 32/M | Headache | Isointense on T1 and T2, homogenous enhancement | Gross total | Transitional | 6m: relapse-free |
| Amirjamshidi et al. (31) | 7/F | Headache and hemiparesis | Calcification, edema, isointense on T1 and T2, vivid enhancement | Gross total | Meningothelial | 13y: relapse-free |
| 5/F | Headache, epilepsy, and hemiparesis | Isointense on T1 and T2, homogenous enhancement | Gross total | Meningothelial | 5y: relapse-free | |
| 7/M | Headache, epilepsy, and hemiparesis | Isointense on T1, homogenous enhancement | Gross total | Meningothelial | 2y: relapse-free |